<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva, formerly WebFilings-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.cancergenetics.com/role/CapitalStock" xlink:href="cgix-20140630.xsd#CapitalStock" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/CapitalStockAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#CapitalStockAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cgix-20140630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:href="cgix-20140630.xsd#ConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/Contingencies" xlink:href="cgix-20140630.xsd#Contingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:href="cgix-20140630.xsd#DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/DocumentAndEntityInformation" xlink:href="cgix-20140630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurements" xlink:href="cgix-20140630.xsd#FairValueMeasurements" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="cgix-20140630.xsd#FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueMeasurementsTables" xlink:href="cgix-20140630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrants" xlink:href="cgix-20140630.xsd#FairValueOfWarrants" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/FairValueOfWarrantsTables" xlink:href="cgix-20140630.xsd#FairValueOfWarrantsTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/JointVentureAgreement" xlink:href="cgix-20140630.xsd#JointVentureAgreement" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/JointVentureAgreementAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#JointVentureAgreementAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/LetterOfCredit" xlink:href="cgix-20140630.xsd#LetterOfCredit" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/LetterOfCreditAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#LetterOfCreditAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCredit" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCredit" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditTables" xlink:href="cgix-20140630.xsd#NotesPayableAndLineOfCreditTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RelatedPartyTransactions" xlink:href="cgix-20140630.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#RelatedPartyTransactionsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivable" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivable" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableTables" xlink:href="cgix-20140630.xsd#RevenueAndAccountsReceivableTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPolicies" xlink:href="cgix-20140630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesPolicies" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/SignificantAccountingPoliciesTables" xlink:href="cgix-20140630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlans" xlink:href="cgix-20140630.xsd#StockOptionPlans" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansTables" xlink:href="cgix-20140630.xsd#StockOptionPlansTables" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:href="cgix-20140630.xsd#StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/Warrants" xlink:href="cgix-20140630.xsd#Warrants" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsAdditionalInformationDetail" xlink:href="cgix-20140630.xsd#WarrantsAdditionalInformationDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsSummaryOfWarrantActivityDetail" xlink:href="cgix-20140630.xsd#WarrantsSummaryOfWarrantActivityDetail" xlink:type="simple" />
  <roleRef roleURI="http://www.cancergenetics.com/role/WarrantsTables" xlink:href="cgix-20140630.xsd#WarrantsTables" xlink:type="simple" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/CapitalStock" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/CapitalStockAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0ce13e30-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_0d216a96-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0ce13e30-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AssetsCurrent_0d216a96-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18320242-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0d216a96-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18320242-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_05404162-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0d216a96-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_05404162-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_83b7103e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0d216a96-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_OtherAssetsCurrent_83b7103e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_940b342e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0ce13e30-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_940b342e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0ce13e30-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_325d494c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_325d494c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a1d0a602-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a1d0a602-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_7da2aae6-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_7da2aae6-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_665b26a6-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_665b26a6-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6ae6abb4-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_837d6190-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6ae6abb4-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e1ed1d0-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e1ed1d0-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_0520d304-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_0520d304-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_14b6c54e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_14b6c54e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_2a991f10-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_DeferredRevenueCurrent_2a991f10-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_7dc3bcc2-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NotesPayableCurrent_7dc3bcc2-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_718337bc-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e17fb62-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_LinesOfCreditCurrent_718337bc-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_14cfe57e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_14cfe57e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_2a6c0c50-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_2a6c0c50-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaap_LongTermLineOfCredit_761d7602-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_LongTermLineOfCredit_761d7602-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_32d9963c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6e59ec02-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_DerivativeLiabilities_32d9963c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e1ed1d0-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_8fab7cfe-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_PreferredStockValue_8fab7cfe-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_1e2a510e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_CommonStockValue_1e2a510e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_06e972fe-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AdditionalPaidInCapital_06e972fe-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a33a731a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_adc32df4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a33a731a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_181e990a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_181e990a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_a110814c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_a110814c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_92ddc436-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_92ddc436-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_91af78ca-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_91af78ca-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9308e58a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9308e58a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_a1232d92-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_a1232d92-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8b69df8c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ca2b500-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8b69df8c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c8e1730-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_181e990a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c8e1730-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b21b464-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c8e1730-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b21b464-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCash_63cd9f36-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c8e1730-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCash_63cd9f36-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_8b6ec042-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c8e1730-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_8b6ec042-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_181e990a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_3283801c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_Depreciation_3283801c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_072ed9b6-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AdjustmentForAmortization_072ed9b6-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationConsulting" xlink:label="loc_cgix_ShareBasedCompensationConsulting_50f91e2e-2167-11e4-b035-22000a1e8102" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_cgix_ShareBasedCompensationConsulting_50f91e2e-2167-11e4-b035-22000a1e8102" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_ShareBasedCompensationResearchAndDevelopment" xlink:label="loc_cgix_ShareBasedCompensationResearchAndDevelopment_e16ad7fa-20e9-11e4-b035-22000a1e8102" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_cgix_ShareBasedCompensationResearchAndDevelopment_e16ad7fa-20e9-11e4-b035-22000a1e8102" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_485fe8d0-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_485fe8d0-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_0c1127ae-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_0c1127ae-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense_0599cb42-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_AccretionExpense_0599cb42-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_IncreaseDecreaseDeferredRentExpense" xlink:label="loc_cgix_IncreaseDecreaseDeferredRentExpense_a8e3d78f-9e7a-a986-73f3-ce1918ff7ede" xlink:type="locator" />
    <calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_cgix_IncreaseDecreaseDeferredRentExpense_a8e3d78f-9e7a-a986-73f3-ce1918ff7ede" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_601d37fc-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_601d37fc-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_83c77c94-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_83c77c94-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="cgix-20140630.xsd#cgix_GainLossOnConversionOfDebt" xlink:label="loc_cgix_GainLossOnConversionOfDebt_29cf2186-20ea-11e4-b035-22000a1e8102" xlink:type="locator" />
    <calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_cgix_GainLossOnConversionOfDebt_29cf2186-20ea-11e4-b035-22000a1e8102" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_62c142a0-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_62c142a0-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_6302324c-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="13" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_6302324c-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_6368126a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_6368126a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="15" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7cb5e5da-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.cancergenetics.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6058d0a0-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6058d0a0-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8028df7e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6058d0a0-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_OperatingIncomeLoss_8028df7e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_5c8cb1f8-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8028df7e-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_GrossProfit_5c8cb1f8-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_a489395e-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5c8cb1f8-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_Revenues_a489395e-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_235acf32-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5c8cb1f8-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_CostOfRevenue_235acf32-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_800dbf32-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8028df7e-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_OperatingExpenses_800dbf32-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a17a5cf2-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_800dbf32-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a17a5cf2-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5b9b5a38-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_800dbf32-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5b9b5a38-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_aacb810a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_800dbf32-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_SellingAndMarketingExpense_aacb810a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6058d0a0-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_678fa826-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_InterestExpense_678fa826-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6a12f3d2-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6a12f3d2-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ad54e60-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ad54e60-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_485fe8d0-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7d82877a-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_485fe8d0-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_610ca94a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_610ca94a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.cancergenetics.com/role/Contingencies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationAcquisitionPendingAcquisitionPublicOfferingsAndReverseStockSplits" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/DescriptionOfBusinessBasisOfPresentationPendingAcquisitionPublicOfferingsAndReverseStockSplitsAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurements" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurementsSummaryOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrants" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsAssumptionsUsedInComputingFairValueOfDerivativeWarrantsDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsSummaryOfDerivativeWarrantActivityDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/FairValueOfWarrantsTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/JointVentureAgreement" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/JointVentureAgreementAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/LetterOfCredit" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/LetterOfCreditAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCredit" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditSummaryOfShortTermAndLongTermDebtObligationsDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/NotesPayableAndLineOfCreditTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RelatedPartyTransactions" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivable" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfAccountsReceivableByPayorTypeDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableScheduleOfRevenueByPayorTypeDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/RevenueAndAccountsReceivableTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPolicies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesComputationOfBasicNetIncomeLossAndDilutedNetLossPerShareDataDetail" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b93d27d4-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b91dcd62-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b93d27d4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b91dcd62-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_652b15b6-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b93d27d4-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_652b15b6-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaap_DilutiveSecurities_3a2b1e10-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_DilutiveSecurities_3a2b1e10-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_7c8c3c8a-9656-11e2-88e7-12313d1a0274" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc2c354-9656-11e2-88e7-12313d1a0274" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_7c8c3c8a-9656-11e2-88e7-12313d1a0274" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesSummaryOfPotentiallyDilutiveAdjustmentsToWeightedAverageNumberOfCommonSharesExcludedFromCalculationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/SignificantAccountingPoliciesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlans" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansEffectsOfStockBasedCompensationRelatedToStockOptionAwardsDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfEmployeeAndNonemployeeStockOptionActivityDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansSummaryOfOutstandingAndVestedStockOptionsGrantedDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/StockOptionPlansWeightedAverageAssumptionsUsedToEstimateFairValueOfOptionsGrantedDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/Warrants" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/WarrantsAdditionalInformationDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/WarrantsSummaryOfWarrantActivityDetail" xlink:type="extended" />
  <calculationLink xlink:role="http://www.cancergenetics.com/role/WarrantsTables" xlink:type="extended" />
</linkbase>


